| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.03 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.4 | 0.03 |